Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Coronary Artery Disease | 63 | 2024 | 6551 | 3.800 |
Why?
|
Coronary Angiography | 50 | 2024 | 4526 | 3.750 |
Why?
|
Plaque, Atherosclerotic | 34 | 2024 | 1547 | 3.270 |
Why?
|
Coronary Stenosis | 17 | 2024 | 803 | 3.010 |
Why?
|
Coronary Vessels | 25 | 2024 | 3122 | 2.300 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 14 | 2024 | 3253 | 1.450 |
Why?
|
HIV Infections | 41 | 2024 | 17564 | 1.360 |
Why?
|
Tomography, X-Ray Computed | 32 | 2024 | 20762 | 1.260 |
Why?
|
Chest Pain | 17 | 2023 | 1099 | 1.230 |
Why?
|
Atherosclerosis | 11 | 2024 | 3431 | 1.170 |
Why?
|
Cardiovascular Diseases | 22 | 2024 | 15638 | 1.080 |
Why?
|
Angina Pectoris | 7 | 2019 | 960 | 1.080 |
Why?
|
Acute Coronary Syndrome | 12 | 2024 | 2195 | 1.060 |
Why?
|
Quinolines | 5 | 2024 | 769 | 1.030 |
Why?
|
Fractional Flow Reserve, Myocardial | 4 | 2024 | 347 | 0.840 |
Why?
|
Risk Assessment | 35 | 2024 | 24311 | 0.800 |
Why?
|
Rehabilitation Centers | 1 | 2024 | 250 | 0.800 |
Why?
|
Predictive Value of Tests | 39 | 2024 | 15460 | 0.760 |
Why?
|
Echocardiography, Stress | 3 | 2017 | 139 | 0.710 |
Why?
|
Radiography, Thoracic | 4 | 2024 | 1320 | 0.710 |
Why?
|
Medication Therapy Management | 1 | 2020 | 131 | 0.670 |
Why?
|
Radiology Information Systems | 2 | 2014 | 533 | 0.620 |
Why?
|
Myocardial Perfusion Imaging | 1 | 2024 | 672 | 0.610 |
Why?
|
Middle Aged | 103 | 2024 | 223418 | 0.600 |
Why?
|
Incidental Findings | 3 | 2017 | 699 | 0.600 |
Why?
|
Musculoskeletal Diseases | 1 | 2024 | 601 | 0.590 |
Why?
|
Risk Factors | 60 | 2024 | 74915 | 0.580 |
Why?
|
Heart Ventricles | 6 | 2020 | 3839 | 0.580 |
Why?
|
Referral and Consultation | 2 | 2024 | 3629 | 0.570 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 9 | 2024 | 1226 | 0.560 |
Why?
|
Pulmonary Embolism | 8 | 2020 | 2591 | 0.550 |
Why?
|
Lung Neoplasms | 6 | 2024 | 13589 | 0.550 |
Why?
|
Lacrimal Apparatus | 6 | 2015 | 223 | 0.520 |
Why?
|
Solitary Pulmonary Nodule | 2 | 2017 | 281 | 0.510 |
Why?
|
Male | 106 | 2024 | 364781 | 0.490 |
Why?
|
Female | 114 | 2024 | 396943 | 0.480 |
Why?
|
Adipose Tissue | 6 | 2023 | 3335 | 0.480 |
Why?
|
Early Detection of Cancer | 5 | 2022 | 3230 | 0.470 |
Why?
|
Humans | 146 | 2024 | 768451 | 0.440 |
Why?
|
Radionuclide Imaging | 1 | 2017 | 1998 | 0.430 |
Why?
|
Angiography | 4 | 2016 | 1598 | 0.420 |
Why?
|
Lung Diseases | 2 | 2023 | 1926 | 0.420 |
Why?
|
Inpatients | 2 | 2024 | 2561 | 0.420 |
Why?
|
Asymptomatic Diseases | 6 | 2021 | 591 | 0.370 |
Why?
|
Radiography, Abdominal | 1 | 2014 | 541 | 0.370 |
Why?
|
Fee-for-Service Plans | 1 | 2016 | 714 | 0.360 |
Why?
|
Exercise Test | 4 | 2020 | 2186 | 0.360 |
Why?
|
Sjogren's Syndrome | 4 | 2015 | 242 | 0.360 |
Why?
|
Lipoproteins, LDL | 4 | 2024 | 644 | 0.350 |
Why?
|
Insulin, Long-Acting | 1 | 2010 | 59 | 0.350 |
Why?
|
Artificial Intelligence | 1 | 2024 | 2659 | 0.330 |
Why?
|
Pericardium | 3 | 2020 | 679 | 0.330 |
Why?
|
Radiation Dosage | 2 | 2017 | 1973 | 0.330 |
Why?
|
Patellar Ligament | 1 | 2009 | 66 | 0.320 |
Why?
|
Calcium | 6 | 2023 | 5793 | 0.320 |
Why?
|
Dacryocystitis | 3 | 2015 | 68 | 0.310 |
Why?
|
HIV | 8 | 2023 | 1596 | 0.300 |
Why?
|
Aged | 44 | 2024 | 171520 | 0.290 |
Why?
|
Triage | 2 | 2023 | 997 | 0.290 |
Why?
|
Retrospective Studies | 27 | 2024 | 81834 | 0.290 |
Why?
|
Anatomy, Cross-Sectional | 1 | 2007 | 139 | 0.280 |
Why?
|
Prognosis | 25 | 2024 | 30028 | 0.280 |
Why?
|
Cytomegalovirus Infections | 2 | 2024 | 839 | 0.270 |
Why?
|
Myocardial Revascularization | 3 | 2020 | 796 | 0.270 |
Why?
|
Ventricular Dysfunction, Right | 2 | 2013 | 645 | 0.270 |
Why?
|
Cardiac Surgical Procedures | 1 | 2022 | 3682 | 0.270 |
Why?
|
Point-of-Care Systems | 1 | 2015 | 1228 | 0.270 |
Why?
|
Lung | 6 | 2023 | 10090 | 0.270 |
Why?
|
Models, Cardiovascular | 3 | 2020 | 986 | 0.270 |
Why?
|
Aortic Diseases | 1 | 2012 | 742 | 0.270 |
Why?
|
Smoking | 2 | 2020 | 9099 | 0.270 |
Why?
|
Decision Support Systems, Clinical | 1 | 2015 | 1176 | 0.260 |
Why?
|
Practice Guidelines as Topic | 4 | 2020 | 7451 | 0.260 |
Why?
|
Aorta | 2 | 2017 | 2046 | 0.250 |
Why?
|
Joint Diseases | 1 | 2009 | 460 | 0.250 |
Why?
|
Radiographic Image Enhancement | 2 | 2007 | 878 | 0.250 |
Why?
|
Magnetic Resonance Angiography | 1 | 2012 | 1434 | 0.250 |
Why?
|
Guideline Adherence | 1 | 2015 | 2239 | 0.250 |
Why?
|
Coronary Care Units | 1 | 2016 | 235 | 0.240 |
Why?
|
Aortic Valve Stenosis | 3 | 2023 | 2032 | 0.240 |
Why?
|
North America | 5 | 2024 | 1292 | 0.240 |
Why?
|
Patient Transfer | 1 | 2012 | 796 | 0.240 |
Why?
|
Heart Valve Diseases | 1 | 2012 | 1033 | 0.240 |
Why?
|
Troponin I | 3 | 2022 | 662 | 0.230 |
Why?
|
Constriction, Pathologic | 4 | 2024 | 1103 | 0.220 |
Why?
|
Prospective Studies | 22 | 2024 | 54914 | 0.210 |
Why?
|
Troponin | 2 | 2024 | 534 | 0.210 |
Why?
|
Inflammation | 10 | 2024 | 10865 | 0.210 |
Why?
|
Stroke | 4 | 2023 | 9791 | 0.210 |
Why?
|
Reproducibility of Results | 15 | 2024 | 20231 | 0.210 |
Why?
|
Electrocardiography | 4 | 2019 | 6410 | 0.210 |
Why?
|
Ventricular Dysfunction, Left | 2 | 2017 | 2145 | 0.210 |
Why?
|
Hypoglycemia | 1 | 2010 | 894 | 0.210 |
Why?
|
Phosphatidylcholine-Sterol O-Acyltransferase | 1 | 2022 | 33 | 0.200 |
Why?
|
Medicare | 2 | 2022 | 6881 | 0.200 |
Why?
|
Dementia | 1 | 2017 | 2723 | 0.200 |
Why?
|
Anterior Wall Myocardial Infarction | 1 | 2022 | 42 | 0.200 |
Why?
|
Radiography | 3 | 2023 | 6995 | 0.200 |
Why?
|
Lymphoma, Follicular | 1 | 2006 | 460 | 0.200 |
Why?
|
Hypertrophy, Right Ventricular | 2 | 2013 | 109 | 0.190 |
Why?
|
Hematoma | 1 | 2006 | 768 | 0.190 |
Why?
|
Retreatment | 2 | 2014 | 601 | 0.190 |
Why?
|
Proteinuria | 1 | 2024 | 613 | 0.190 |
Why?
|
Suicide, Attempted | 1 | 2010 | 1409 | 0.190 |
Why?
|
Cholesterol | 3 | 2022 | 2910 | 0.180 |
Why?
|
Adult | 38 | 2024 | 223542 | 0.180 |
Why?
|
Journal Impact Factor | 1 | 2022 | 154 | 0.180 |
Why?
|
Albuminuria | 1 | 2024 | 658 | 0.180 |
Why?
|
X-Rays | 1 | 2021 | 312 | 0.180 |
Why?
|
Amino Acids | 2 | 2018 | 1714 | 0.170 |
Why?
|
Cardiac Volume | 1 | 2021 | 197 | 0.170 |
Why?
|
Thorax | 2 | 2023 | 559 | 0.170 |
Why?
|
Fibrosis | 2 | 2018 | 2076 | 0.170 |
Why?
|
Pulmonary Edema | 1 | 2023 | 409 | 0.170 |
Why?
|
Aorta, Thoracic | 1 | 2006 | 1107 | 0.170 |
Why?
|
Spironolactone | 1 | 2023 | 412 | 0.170 |
Why?
|
Lipoprotein(a) | 1 | 2024 | 488 | 0.170 |
Why?
|
Lymphoma, B-Cell | 1 | 2006 | 945 | 0.170 |
Why?
|
Sodium-Potassium-Exchanging ATPase | 2 | 2012 | 478 | 0.160 |
Why?
|
AIDS-Associated Nephropathy | 1 | 2019 | 34 | 0.160 |
Why?
|
Double-Blind Method | 6 | 2024 | 12450 | 0.160 |
Why?
|
Sensitivity and Specificity | 5 | 2020 | 14728 | 0.150 |
Why?
|
Imaging, Three-Dimensional | 2 | 2012 | 4077 | 0.150 |
Why?
|
Fatty Liver | 1 | 2024 | 807 | 0.150 |
Why?
|
Stress, Mechanical | 2 | 2020 | 1680 | 0.150 |
Why?
|
Rupture, Spontaneous | 3 | 2018 | 365 | 0.150 |
Why?
|
American Heart Association | 2 | 2020 | 1049 | 0.150 |
Why?
|
Nitroglycerin | 1 | 2019 | 332 | 0.150 |
Why?
|
Macrophages | 3 | 2024 | 5797 | 0.150 |
Why?
|
Multiple Pulmonary Nodules | 2 | 2017 | 174 | 0.150 |
Why?
|
Elasticity | 1 | 2020 | 658 | 0.150 |
Why?
|
Psoas Muscles | 1 | 2018 | 66 | 0.150 |
Why?
|
Cardiovascular System | 2 | 2023 | 838 | 0.150 |
Why?
|
Anti-Mullerian Hormone | 1 | 2020 | 415 | 0.150 |
Why?
|
Hypoglycemic Agents | 1 | 2010 | 3111 | 0.140 |
Why?
|
Dry Eye Syndromes | 2 | 2012 | 388 | 0.140 |
Why?
|
Body Composition | 2 | 2024 | 2455 | 0.140 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2009 | 2173 | 0.140 |
Why?
|
Performance-Enhancing Substances | 1 | 2017 | 30 | 0.140 |
Why?
|
Doping in Sports | 1 | 2017 | 62 | 0.140 |
Why?
|
Testosterone Congeners | 1 | 2017 | 62 | 0.140 |
Why?
|
Weight Lifting | 1 | 2017 | 130 | 0.140 |
Why?
|
Cushing Syndrome | 1 | 2018 | 241 | 0.130 |
Why?
|
T-Lymphocyte Subsets | 1 | 2024 | 1814 | 0.130 |
Why?
|
Myocardial Infarction | 6 | 2024 | 11515 | 0.130 |
Why?
|
Severity of Illness Index | 9 | 2024 | 15965 | 0.130 |
Why?
|
Randomized Controlled Trials as Topic | 8 | 2022 | 10358 | 0.130 |
Why?
|
United States | 13 | 2023 | 73121 | 0.130 |
Why?
|
Thymus Neoplasms | 1 | 2018 | 278 | 0.130 |
Why?
|
Diabetes Mellitus | 4 | 2024 | 5887 | 0.120 |
Why?
|
Aquaporin 5 | 2 | 2011 | 8 | 0.120 |
Why?
|
Necrobiotic Disorders | 1 | 2014 | 5 | 0.120 |
Why?
|
Purpura | 1 | 2016 | 117 | 0.120 |
Why?
|
Anti-HIV Agents | 4 | 2020 | 4567 | 0.120 |
Why?
|
Time Factors | 9 | 2019 | 40271 | 0.120 |
Why?
|
Treatment Outcome | 11 | 2023 | 65409 | 0.120 |
Why?
|
Cardiac Imaging Techniques | 1 | 2017 | 281 | 0.120 |
Why?
|
Prevalence | 10 | 2024 | 15880 | 0.120 |
Why?
|
Vasodilation | 1 | 2019 | 968 | 0.120 |
Why?
|
Vasodilator Agents | 1 | 2019 | 991 | 0.120 |
Why?
|
Cranial Irradiation | 1 | 2017 | 395 | 0.120 |
Why?
|
Serum | 1 | 2016 | 208 | 0.120 |
Why?
|
Contrast Media | 4 | 2014 | 5336 | 0.120 |
Why?
|
Subcutaneous Fat | 1 | 2018 | 402 | 0.120 |
Why?
|
Utilization Review | 1 | 2016 | 384 | 0.120 |
Why?
|
Interleukin-10 | 1 | 2020 | 1185 | 0.120 |
Why?
|
Arteritis | 1 | 2016 | 158 | 0.110 |
Why?
|
Hemodynamics | 3 | 2020 | 4202 | 0.110 |
Why?
|
Mass Screening | 3 | 2022 | 5455 | 0.110 |
Why?
|
Consensus | 1 | 2024 | 3207 | 0.110 |
Why?
|
Spondylosis | 1 | 2014 | 85 | 0.110 |
Why?
|
Primary Prevention | 4 | 2024 | 1189 | 0.110 |
Why?
|
Tears | 2 | 2015 | 252 | 0.110 |
Why?
|
Adiposity | 3 | 2020 | 1888 | 0.110 |
Why?
|
Aquaporin 4 | 2 | 2011 | 162 | 0.110 |
Why?
|
Cardiac-Gated Imaging Techniques | 3 | 2019 | 139 | 0.110 |
Why?
|
Aging | 3 | 2024 | 8761 | 0.110 |
Why?
|
Comorbidity | 4 | 2018 | 10601 | 0.110 |
Why?
|
Chi-Square Distribution | 3 | 2017 | 3438 | 0.110 |
Why?
|
Analysis of Variance | 2 | 2012 | 6242 | 0.110 |
Why?
|
Cardiovascular Agents | 1 | 2020 | 849 | 0.110 |
Why?
|
Pain Measurement | 1 | 2024 | 3577 | 0.110 |
Why?
|
Periodicals as Topic | 2 | 2022 | 1468 | 0.110 |
Why?
|
Lumbosacral Region | 1 | 2014 | 294 | 0.110 |
Why?
|
Carotid Arteries | 1 | 2017 | 943 | 0.110 |
Why?
|
Coronary Artery Bypass | 1 | 2022 | 2194 | 0.110 |
Why?
|
RNA, Messenger | 6 | 2015 | 12813 | 0.100 |
Why?
|
Aortic Valve | 3 | 2023 | 1968 | 0.100 |
Why?
|
Intra-Abdominal Fat | 1 | 2018 | 623 | 0.100 |
Why?
|
Length of Stay | 2 | 2024 | 6521 | 0.100 |
Why?
|
Sex Factors | 4 | 2020 | 10647 | 0.100 |
Why?
|
Dyspnea | 2 | 2017 | 1352 | 0.100 |
Why?
|
Diagnosis, Differential | 7 | 2018 | 13026 | 0.100 |
Why?
|
Claudins | 1 | 2013 | 117 | 0.100 |
Why?
|
Menopause | 1 | 2020 | 1651 | 0.100 |
Why?
|
Pregnancy, Animal | 1 | 2012 | 124 | 0.100 |
Why?
|
Magnetic Resonance Imaging | 3 | 2024 | 36840 | 0.100 |
Why?
|
Acute Disease | 5 | 2017 | 7246 | 0.100 |
Why?
|
Ischemic Attack, Transient | 1 | 2017 | 878 | 0.100 |
Why?
|
Rabbits | 6 | 2015 | 4786 | 0.100 |
Why?
|
Neuroendocrine Tumors | 1 | 2018 | 649 | 0.100 |
Why?
|
Registries | 5 | 2018 | 8373 | 0.100 |
Why?
|
Cholesterol, LDL | 4 | 2024 | 2396 | 0.090 |
Why?
|
Multivariate Analysis | 4 | 2017 | 12096 | 0.090 |
Why?
|
Papillomaviridae | 1 | 2017 | 1135 | 0.090 |
Why?
|
Carotid Artery Diseases | 1 | 2017 | 879 | 0.090 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 6 | 2015 | 4586 | 0.090 |
Why?
|
Venous Thrombosis | 1 | 2020 | 1318 | 0.090 |
Why?
|
Dilatation, Pathologic | 1 | 2012 | 528 | 0.090 |
Why?
|
Chloride Channels | 1 | 2012 | 222 | 0.090 |
Why?
|
Blotting, Western | 6 | 2015 | 5042 | 0.090 |
Why?
|
Cohort Studies | 8 | 2023 | 41797 | 0.090 |
Why?
|
Tight Junctions | 1 | 2013 | 325 | 0.090 |
Why?
|
Decision Support Techniques | 1 | 2020 | 2010 | 0.090 |
Why?
|
Aquaporins | 1 | 2011 | 179 | 0.090 |
Why?
|
Thoracic Vertebrae | 1 | 2014 | 613 | 0.090 |
Why?
|
Mortality | 1 | 2021 | 2917 | 0.090 |
Why?
|
ROC Curve | 3 | 2019 | 3624 | 0.080 |
Why?
|
Disease Progression | 4 | 2020 | 13655 | 0.080 |
Why?
|
Androgens | 1 | 2017 | 1285 | 0.080 |
Why?
|
Emergency Service, Hospital | 3 | 2018 | 7956 | 0.080 |
Why?
|
Vaccination | 1 | 2022 | 3434 | 0.080 |
Why?
|
Hydrodynamics | 2 | 2020 | 168 | 0.080 |
Why?
|
Multicenter Studies as Topic | 3 | 2019 | 1727 | 0.080 |
Why?
|
Tricuspid Valve | 1 | 2012 | 419 | 0.080 |
Why?
|
Gadolinium DTPA | 1 | 2012 | 823 | 0.080 |
Why?
|
Vitamin D Deficiency | 1 | 2019 | 1389 | 0.080 |
Why?
|
Cytomegalovirus | 2 | 2024 | 755 | 0.080 |
Why?
|
Heart | 2 | 2023 | 4451 | 0.080 |
Why?
|
Anticholesteremic Agents | 1 | 2016 | 972 | 0.080 |
Why?
|
Anti-Retroviral Agents | 1 | 2018 | 1794 | 0.080 |
Why?
|
Patient Readmission | 2 | 2023 | 3308 | 0.080 |
Why?
|
Amyloidosis | 1 | 2016 | 879 | 0.070 |
Why?
|
Aged, 80 and over | 9 | 2024 | 59680 | 0.070 |
Why?
|
Protein Subunits | 1 | 2011 | 943 | 0.070 |
Why?
|
Heart Diseases | 1 | 2021 | 2816 | 0.070 |
Why?
|
Algorithms | 2 | 2010 | 14158 | 0.070 |
Why?
|
Longitudinal Studies | 2 | 2022 | 14766 | 0.070 |
Why?
|
Spine | 1 | 2014 | 1142 | 0.070 |
Why?
|
Young Adult | 9 | 2021 | 60045 | 0.070 |
Why?
|
Venous Thromboembolism | 1 | 2020 | 1884 | 0.070 |
Why?
|
Fluorescent Antibody Technique | 4 | 2012 | 2477 | 0.070 |
Why?
|
Monocytes | 1 | 2016 | 2591 | 0.070 |
Why?
|
Cell Adhesion Molecules | 1 | 2013 | 1615 | 0.070 |
Why?
|
Placebos | 2 | 2024 | 1668 | 0.070 |
Why?
|
Liver | 2 | 2021 | 7575 | 0.060 |
Why?
|
Viral Load | 3 | 2022 | 3399 | 0.060 |
Why?
|
Bone Marrow | 1 | 2016 | 2929 | 0.060 |
Why?
|
Papillomavirus Infections | 1 | 2017 | 1638 | 0.060 |
Why?
|
HIV-1 | 2 | 2020 | 6966 | 0.060 |
Why?
|
Biomedical Research | 1 | 2021 | 3463 | 0.060 |
Why?
|
Electronic Health Records | 1 | 2022 | 4877 | 0.060 |
Why?
|
Cross-Sectional Studies | 6 | 2024 | 26351 | 0.060 |
Why?
|
Logistic Models | 3 | 2017 | 13324 | 0.060 |
Why?
|
Vitamin D | 1 | 2019 | 3311 | 0.060 |
Why?
|
Antigens, Neoplasm | 1 | 2013 | 2003 | 0.060 |
Why?
|
Observer Variation | 3 | 2018 | 2622 | 0.060 |
Why?
|
Research Design | 1 | 2020 | 6217 | 0.060 |
Why?
|
Clinical Trials, Phase III as Topic | 2 | 2019 | 876 | 0.060 |
Why?
|
Ventricular Function, Left | 1 | 2017 | 3941 | 0.060 |
Why?
|
Decision Making | 1 | 2018 | 3961 | 0.060 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2021 | 9066 | 0.060 |
Why?
|
Automation | 2 | 2017 | 588 | 0.060 |
Why?
|
Gene Expression Regulation | 2 | 2012 | 11930 | 0.060 |
Why?
|
Axilla | 1 | 2006 | 629 | 0.050 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2018 | 3246 | 0.050 |
Why?
|
Clinical Trials as Topic | 1 | 2019 | 8051 | 0.050 |
Why?
|
Disease-Free Survival | 3 | 2018 | 6856 | 0.050 |
Why?
|
Head and Neck Neoplasms | 1 | 2017 | 2915 | 0.050 |
Why?
|
Lecithins | 1 | 2022 | 16 | 0.050 |
Why?
|
Comparative Effectiveness Research | 2 | 2019 | 712 | 0.050 |
Why?
|
RNA, Viral | 2 | 2023 | 2865 | 0.050 |
Why?
|
Fluorodeoxyglucose F18 | 2 | 2014 | 2048 | 0.050 |
Why?
|
Sterol O-Acyltransferase | 1 | 2022 | 28 | 0.050 |
Why?
|
Kaplan-Meier Estimate | 3 | 2017 | 6537 | 0.050 |
Why?
|
Survival Rate | 2 | 2018 | 12875 | 0.050 |
Why?
|
Whole Body Imaging | 1 | 2024 | 285 | 0.050 |
Why?
|
1-Alkyl-2-acetylglycerophosphocholine Esterase | 1 | 2023 | 127 | 0.050 |
Why?
|
Radiopharmaceuticals | 2 | 2017 | 2731 | 0.050 |
Why?
|
Pulmonary Artery | 1 | 2011 | 1949 | 0.050 |
Why?
|
Nucleosides | 1 | 2022 | 131 | 0.050 |
Why?
|
Crohn Disease | 1 | 2014 | 2293 | 0.050 |
Why?
|
Skin | 1 | 2016 | 4520 | 0.050 |
Why?
|
Information Storage and Retrieval | 1 | 2007 | 823 | 0.050 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2017 | 4083 | 0.050 |
Why?
|
Immunoglobulin G | 2 | 2024 | 4572 | 0.050 |
Why?
|
Abdominal Muscles | 1 | 2022 | 172 | 0.050 |
Why?
|
Ultrasonography, Interventional | 2 | 2020 | 1519 | 0.050 |
Why?
|
Lymph Nodes | 2 | 2017 | 3472 | 0.050 |
Why?
|
User-Computer Interface | 1 | 2007 | 1397 | 0.040 |
Why?
|
Accidents, Traffic | 1 | 2006 | 821 | 0.040 |
Why?
|
Substance-Related Disorders | 1 | 2017 | 4453 | 0.040 |
Why?
|
Heart Failure | 3 | 2023 | 11857 | 0.040 |
Why?
|
Respiration, Artificial | 2 | 2023 | 2723 | 0.040 |
Why?
|
Interleukin-6 | 2 | 2022 | 3234 | 0.040 |
Why?
|
Medical Informatics | 1 | 2007 | 737 | 0.040 |
Why?
|
Integrases | 1 | 2022 | 520 | 0.040 |
Why?
|
Publishing | 1 | 2007 | 836 | 0.040 |
Why?
|
Case-Control Studies | 4 | 2019 | 22293 | 0.040 |
Why?
|
Adolescent | 7 | 2019 | 89168 | 0.040 |
Why?
|
Administration, Sublingual | 1 | 2019 | 60 | 0.040 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2012 | 3408 | 0.040 |
Why?
|
Shear Strength | 1 | 2020 | 161 | 0.040 |
Why?
|
Reverse Transcriptase Inhibitors | 1 | 2022 | 622 | 0.040 |
Why?
|
Interleukin-18 | 1 | 2021 | 251 | 0.040 |
Why?
|
Transdermal Patch | 1 | 2019 | 52 | 0.040 |
Why?
|
Muscles | 1 | 2024 | 1582 | 0.040 |
Why?
|
Arteries | 1 | 2024 | 1126 | 0.040 |
Why?
|
Tablets | 1 | 2019 | 149 | 0.040 |
Why?
|
Information Dissemination | 1 | 2007 | 1138 | 0.040 |
Why?
|
Follow-Up Studies | 4 | 2023 | 39430 | 0.040 |
Why?
|
Perfusion | 1 | 2023 | 1402 | 0.040 |
Why?
|
Edema | 1 | 2023 | 766 | 0.040 |
Why?
|
Proportional Hazards Models | 3 | 2017 | 12561 | 0.040 |
Why?
|
Respiratory Sounds | 1 | 2023 | 702 | 0.040 |
Why?
|
Glucose | 1 | 2010 | 4355 | 0.040 |
Why?
|
Alanine Transaminase | 1 | 2021 | 605 | 0.040 |
Why?
|
Hypertension | 1 | 2018 | 8611 | 0.040 |
Why?
|
Child, Preschool | 1 | 2021 | 42623 | 0.040 |
Why?
|
Platelet Count | 1 | 2020 | 786 | 0.040 |
Why?
|
Lipoproteins, HDL | 1 | 2022 | 682 | 0.040 |
Why?
|
Multiple Myeloma | 1 | 2016 | 5192 | 0.040 |
Why?
|
Finite Element Analysis | 1 | 2020 | 441 | 0.040 |
Why?
|
Pregnancy Complications | 1 | 2011 | 2969 | 0.040 |
Why?
|
Technetium Tc 99m Pentetate | 1 | 2017 | 67 | 0.040 |
Why?
|
Receptors, Interleukin-1 | 1 | 2018 | 262 | 0.030 |
Why?
|
Mannans | 1 | 2017 | 58 | 0.030 |
Why?
|
Epithelial Cells | 3 | 2015 | 3697 | 0.030 |
Why?
|
Markov Chains | 1 | 2020 | 977 | 0.030 |
Why?
|
Mannose-Binding Lectins | 1 | 2017 | 96 | 0.030 |
Why?
|
Administration, Cutaneous | 1 | 2019 | 716 | 0.030 |
Why?
|
Tomography, X-Ray | 1 | 2016 | 58 | 0.030 |
Why?
|
Growth Differentiation Factor 15 | 1 | 2018 | 199 | 0.030 |
Why?
|
Aerosols | 1 | 2019 | 637 | 0.030 |
Why?
|
Adrenocorticotropic Hormone | 1 | 2018 | 619 | 0.030 |
Why?
|
Galectin 3 | 1 | 2018 | 240 | 0.030 |
Why?
|
Disease Models, Animal | 5 | 2015 | 18388 | 0.030 |
Why?
|
Confusion | 1 | 2018 | 278 | 0.030 |
Why?
|
Purpura Fulminans | 1 | 2016 | 21 | 0.030 |
Why?
|
Reproduction | 1 | 2020 | 646 | 0.030 |
Why?
|
Muscle Cells | 1 | 2016 | 195 | 0.030 |
Why?
|
Adrenal Glands | 1 | 2018 | 557 | 0.030 |
Why?
|
Obesity | 1 | 2018 | 13065 | 0.030 |
Why?
|
Cardiomegaly | 1 | 2018 | 591 | 0.030 |
Why?
|
Galectins | 1 | 2018 | 296 | 0.030 |
Why?
|
Odds Ratio | 2 | 2017 | 9687 | 0.030 |
Why?
|
Positron-Emission Tomography | 2 | 2014 | 6657 | 0.030 |
Why?
|
Dextrans | 1 | 2017 | 574 | 0.030 |
Why?
|
Internet | 1 | 2007 | 3123 | 0.030 |
Why?
|
Heart Valve Prosthesis | 1 | 2023 | 1468 | 0.030 |
Why?
|
Systole | 1 | 2017 | 938 | 0.030 |
Why?
|
Diastole | 1 | 2017 | 784 | 0.030 |
Why?
|
Tomography, Emission-Computed | 1 | 2017 | 1123 | 0.030 |
Why?
|
Coronary Circulation | 1 | 2020 | 1617 | 0.030 |
Why?
|
Lectins, C-Type | 1 | 2017 | 589 | 0.030 |
Why?
|
Echocardiography | 2 | 2017 | 5043 | 0.030 |
Why?
|
Academic Medical Centers | 1 | 2024 | 2785 | 0.030 |
Why?
|
Phenotype | 2 | 2022 | 16712 | 0.030 |
Why?
|
Risk Adjustment | 1 | 2017 | 603 | 0.030 |
Why?
|
Radiology | 1 | 2007 | 2118 | 0.030 |
Why?
|
Angina, Unstable | 1 | 2017 | 893 | 0.030 |
Why?
|
Heart Valve Prosthesis Implantation | 1 | 2023 | 1569 | 0.030 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2019 | 1066 | 0.030 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2019 | 1518 | 0.030 |
Why?
|
Blood Proteins | 1 | 2018 | 1183 | 0.030 |
Why?
|
Cardiology | 1 | 2024 | 1701 | 0.030 |
Why?
|
Pleural Effusion | 1 | 2016 | 344 | 0.030 |
Why?
|
Antibodies, Viral | 1 | 2024 | 3212 | 0.030 |
Why?
|
Body Mass Index | 2 | 2022 | 13030 | 0.030 |
Why?
|
Caco-2 Cells | 1 | 2013 | 365 | 0.030 |
Why?
|
Host-Pathogen Interactions | 1 | 2021 | 1465 | 0.020 |
Why?
|
Minority Groups | 1 | 2019 | 1215 | 0.020 |
Why?
|
Software | 2 | 2017 | 4463 | 0.020 |
Why?
|
Sex Characteristics | 1 | 2023 | 2666 | 0.020 |
Why?
|
Boston | 2 | 2018 | 9361 | 0.020 |
Why?
|
Hospitalization | 3 | 2017 | 10845 | 0.020 |
Why?
|
Sodium-Potassium-Chloride Symporters | 1 | 2012 | 106 | 0.020 |
Why?
|
Eye Proteins | 1 | 2015 | 633 | 0.020 |
Why?
|
Spleen | 1 | 2017 | 2298 | 0.020 |
Why?
|
Area Under Curve | 1 | 2015 | 1640 | 0.020 |
Why?
|
Rose Bengal | 1 | 2011 | 115 | 0.020 |
Why?
|
Exanthema | 1 | 2016 | 504 | 0.020 |
Why?
|
Stroke Volume | 2 | 2017 | 5620 | 0.020 |
Why?
|
Fatal Outcome | 1 | 2016 | 1840 | 0.020 |
Why?
|
Fatigue | 1 | 2018 | 1556 | 0.020 |
Why?
|
Disease Susceptibility | 1 | 2018 | 1797 | 0.020 |
Why?
|
Outpatients | 1 | 2019 | 1607 | 0.020 |
Why?
|
Pregnancy | 4 | 2015 | 30179 | 0.020 |
Why?
|
Residence Characteristics | 1 | 2020 | 2119 | 0.020 |
Why?
|
Ventricular Remodeling | 1 | 2018 | 1280 | 0.020 |
Why?
|
Glomerular Filtration Rate | 1 | 2019 | 2226 | 0.020 |
Why?
|
CD4 Lymphocyte Count | 1 | 2016 | 2596 | 0.020 |
Why?
|
Animals | 7 | 2020 | 169418 | 0.020 |
Why?
|
Monitoring, Physiologic | 1 | 2017 | 1795 | 0.020 |
Why?
|
Autoimmune Diseases | 2 | 2012 | 2260 | 0.020 |
Why?
|
Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2012 | 451 | 0.020 |
Why?
|
Proteomics | 1 | 2022 | 3901 | 0.020 |
Why?
|
Gene Expression | 2 | 2011 | 7605 | 0.020 |
Why?
|
C-Reactive Protein | 1 | 2020 | 3854 | 0.020 |
Why?
|
Models, Theoretical | 1 | 2020 | 3590 | 0.020 |
Why?
|
Ventricular Function, Right | 1 | 2013 | 629 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2013 | 1608 | 0.020 |
Why?
|
Communication | 1 | 2022 | 3910 | 0.020 |
Why?
|
Muscle, Skeletal | 1 | 2023 | 4984 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2019 | 5308 | 0.020 |
Why?
|
Word Processing | 1 | 2007 | 7 | 0.020 |
Why?
|
Receptors, Cell Surface | 1 | 2017 | 2819 | 0.020 |
Why?
|
Cost-Benefit Analysis | 1 | 2020 | 5532 | 0.020 |
Why?
|
Regression Analysis | 1 | 2017 | 6353 | 0.020 |
Why?
|
Tomography, Optical Coherence | 1 | 2020 | 2958 | 0.020 |
Why?
|
Myocardial Ischemia | 1 | 2018 | 2139 | 0.020 |
Why?
|
Cell Adhesion | 1 | 2013 | 3103 | 0.020 |
Why?
|
Microscopy, Confocal | 1 | 2011 | 1977 | 0.020 |
Why?
|
Transfection | 1 | 2013 | 5767 | 0.020 |
Why?
|
Spinal Fusion | 1 | 2014 | 1310 | 0.020 |
Why?
|
Health Status | 1 | 2018 | 4096 | 0.010 |
Why?
|
Patient Selection | 1 | 2017 | 4266 | 0.010 |
Why?
|
Orthopedic Procedures | 1 | 2014 | 1280 | 0.010 |
Why?
|
Brain Ischemia | 1 | 2017 | 3038 | 0.010 |
Why?
|
Cornea | 1 | 2011 | 1332 | 0.010 |
Why?
|
Wounds and Injuries | 1 | 2016 | 2518 | 0.010 |
Why?
|
Databases, Factual | 1 | 2017 | 8081 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2023 | 15880 | 0.010 |
Why?
|
Cooperative Behavior | 1 | 2007 | 1514 | 0.010 |
Why?
|
Incidence | 1 | 2017 | 21552 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2012 | 11138 | 0.010 |
Why?
|
Child | 1 | 2014 | 80863 | 0.000 |
Why?
|